Evidence map›Paper›PMID 32208993›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2020

Delisting

Robert A Hegele, Joshua W Knowles, Jay D Horton

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Role of B Lymphocytes in the Pathogenesis of NAFLD: A 2022 Update.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Robert A HegeleFrom the Departments of Medicine and Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.).
Joshua W KnowlesDepartment of Internal Medicine, Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University, Palo Alto, CA (J.W.K.).
Jay D HortonDepartments of Internal Medicine and Molecular Genetics, Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas (J.D.H.).

Funding

TRANSCRIPTIONAL REGULATION OF LDL RECEPTOR PROMOTERP01HL020948 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GOLDSTEIN, JOSEPH L · 1985 to 2021
$103.1M
NHLBI NIH HHS P01 HL020948
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HypercholesterolemiaHyperlipoproteinemia Type IIAdaptor Proteins, Signal TransducingAnimalsApolipoproteins BCholesterol, LDLHumansMiceReceptors, LDLAdaptor Proteins, Signal TransducingApolipoproteins BCholesterol, LDLReceptors, LDLSTAP1 protein, humanallelesapolipoprotein BatherosclerosisEditorialsgenetic diagnosisheterozygotehumansLDL cholesterol

Identifiers

PMID32208993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.